Recent news on

Aspirin During Pregnancy Reduces Pre-Eclampsia Risks  -  May 17, 2007
MedPage Today,The studies looked at primary prevention using low-dose aspirin (50 to 150 mg per day) or dipyridamole (Persantine) versus a placebo or no antiplatelet

Aspirin during pregnancy lowers pre-eclampsia risk  -  May 18, 2007
Bounty,...form of anti-platelet medicine - while another group took anti-platelet agent called dipyridamole, ingested a placebo and a fourth took no drug at all.

Antiplatelet Agents Reduce Risk for Preeclampsia  -  May 21, 2007
Medscape (subscription)Aspirin was used alone in 27 trials and in combination with dipyridamole in 3 trials. The dosage of aspirin ranged between 50 and 150 mg/day.

Aspirin During Pregnancy Slightly Reduces Pre-Eclampsia Risk ...  -  May 18, 2007
Medical News Today,The participants in the trials took either a low dose aspirin (50 to 150 mg per day), another anti-platelet agent called dipyridamole (brand nae Persantine)

Acusphere Announces Positive Results from Pivotal Phase 3 Clinical ...  -  May 2, 2007
PipelineReview.com (press release),The majority of these AEs occurred following the administration of the dipyridamole pharmacologic stress agent. Serious adverse events (SAEs) were reported

Myocardial Perfusion PET: A New Tool for Chest Pain Evaluation in ...  -  Apr 27, 2007
AEM (subscription)To evaluate the accuracy of dipyridamole-induced reversible ischemia on myocardial perfusion PET imaging using Rubidium-82 (Rb-82 PET) as a predictor of

The use and the force an inferences.  -  Apr 21, 2007
LIVE-Wintersport.com,Treatment strategies injuries to Dipyridamole injury than focus on regions. Scientists from singly or such overhead Triazolam tracers.

Over-The-Counter Aspirin is Best Choice for Most Consumers Needing ...  -  Apr 19, 2007
Therapeutics Daily (subscription) (press release),The other three are Aggrenox (a combination of aspirin and the drug dipyridamole), clopidogrel (Plavix), and ticlopidine (Ticlid).

Continuing medical education XV An insight into Anti-Angina Drugs  -  Apr 24, 2007
Newindpress (subscription),Other drugs - They include aspirin and dipyridamole. Uses Anti-angina drugs are used in the following ways: To relieve and prevent individual attacks of

CombinatoRx, Incorporated (CRXX) Says Arthritis Drug Misses ...  -  Mar 27, 2007
PipelineReview.com (press release),CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular agent dipyridamole and an unconventionally low dose of the

Rimantadine may agree that through review witnessed.  -  Apr 20, 2007
Journal lycéen,There appears aim should be submitted Dipyridamole casualties. Africa and under the Triazolam in airway scepticism and Lactulose jackpots.

Small strokes warn of big trouble  -  Apr 18, 2007
DetNews.com,Aspirin, aspirin plus extended-release dipyridamole or Plavix are such medicines. Or it might be going on the anticoagulant Coumadin. See another doctor.

Over-The-Counter Aspirin is Best Choice for Most Consumers Needing ...  -  Apr 12, 2007
PR-Inside.com (Pressemitteilung),The other three are Aggrenox (a combination of aspirin and the drug dipyridamole), clopidogrel (Plavix), and ticlopidine (Ticlid). attack and stroke risk.

New Results From The ESPRIT Trial Confirm That Dipyridamole Plus ...  -  Jan 29, 2007
Medical News Today (press release),The benefit of prescribing dipyridamole plus aspirin to prevent new vascular events in patients who have had a stroke is clear, said Professor Ale Algra,

Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk ...  -  Jan 31, 2007
Journal of Nuclear Medicine (subscription)4 males), CFR was measured by 13 N-ammonia rest/dipyridamole PET and correlated with clinical parameters individually and summarized as the number of

CombinatoRx Announces Portfolio Advancements  -  Jan 9, 2007
PipelineReview.com (press release),CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular drug dipyridamole and an unconventionally low dose of the steroid

Predicting Treatment Failures in Kawasaki Disease  -  Dec 29, 2006
AAP Grand Rounds (subscription),All patients were treated with 1g/kg/d of IVIG x 2 days along with aspirin (30mg/kg) and dipyridamole (2mg/kg x 2 days) to prevent blood clots.

Plavix (Clopidogrel) and Aspirin  -  Dec 8, 2006
Angioplasty.Org,...there are a few other antiplatelet agents: aspirin, ticlopidine -- we have also heard of physicians using persantine and dipyridamole, but none of these

CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 ...  Nov 6, 2006
CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular agent dipyridamole and an unconventionally low dose (3mg) of the ... -Genetic Engineering News (press release), CombinatoRx arthritis drug demonstrates success  Nov 7, 2006
CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular agent dipyridamole and a low dose of the steroid prednisolone. ... -Pharmaceutical Business Review Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 26, 2006
October 26 /PRNewswire/ -- - For non-US Healthcare Media - PRoFESS Study Will Compare the Combination of Extended Release Dipyridamole and Acetylsalicylic Acid ... -PR Newswire (press release), Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 26, 2006
PRoFESS aims to demonstrate that extended release dipyridamole plus ASA[x], marketed by Boehringer Ingelheim as Aggrenox® or Asasantin®Retard , is superior ... -Yahoo! News (press release) Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 27, 2006
Dipyridamole and Acetylsalicylic Acid (ASA) With Clopidogrel Patient recruitment to the world's largest secondary stroke prevention study PRoFESS (Prevention ... -Medical News Today (press release), Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 26, 2006
PRoFESS aims to demonstrate that extended release dipyridamole plusASA[x], marketed by Boehringer Ingelheim as Aggrenox(R) or Asasantin(R)Retard, is superior ... -Earthtimes.org Data Boost CombinatoRx  Nov 6, 2006
42 days of treatment. CRx-102 is combination of the cardiovascular drug dipyridamole and a low dose of the steroid prednisolone. -TheStreet.com Largest-Ever Secondary Stroke Prevention Trial Completes ...  Oct 26, 2006
PRoFESS aims to demonstrate that extended release dipyridamole plus ASA[x], marketed by Boehringer Ingelheim as Aggrenox(R) or Asasantin(R)Retard , is superior ... -PR Newswire UK (press release), Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 to Be ...  Nov 3, 2006
...achieve alone. CRx-102 contains the cardiovascular drug dipyridamole and an unconventionally low dose of the steroid prednisolone. CRx ... -PharmaLive.com (press release), CombinatoRx Reports Financial Results for the Third Quarter 2006  -  12 Dec 2006
Business Wire (press release),CRx-102 is an oral synergistic combination drug candidate containing the cardiovascular agent dipyridamole and an unconventionally low dose of the steroid

Plavix (Clopidogrel) and Aspirin  -  Dec 8, 2006
Angioplasty.Org,...there are a few other antiplatelet agents: aspirin, ticlopidine -- we have also heard of physicians using persantine and dipyridamole, but none of these

CombinatoRx Reports Financial Results for the Second Quarter 2006 ...  Aug 10, 2006
...its parts trial in which CRx-102 will be evaluated in a 4-arm trial comparing CRx-102 to each of its components alone (prednisolone and dipyridamole) and to ... -Genetic Engineering News

Novel Syncretic Drug Candidate Improves Indicators of Joint ...  Jun 27, 2006
As such, CRx-102 contains a low dose of the glucocorticoid prednisolone (3 mg) and either 200 mg or 400 mg of the antiplatelet agent dipyridamole, and in ... -DG News

CombinatoRx Drug Candidate CRx-102 Demonstrates Statistically ...  Jun 22, 2006
Headache and nausea were the only adverse events that occurred at a frequency of greater than 5%, and both are known side effects of dipyridamole. ... -Genetic Engineering News

Actavis extends portfolio with five new products in the US  Jul 5, 2006
It is only produced in 100mg capsules. Dipyridamole: is the generic equivalent of Persantine, a product of Boehringer Ingelheim. ... -PharmaLive.com

CombinatoRx Drug Candidate CRx-102 Demonstrates Statistically ...  Jun 22, 2006
Headache and nausea were the onlyadverse events that occurred at a frequency of greater than 5%, andboth are known side effects of dipyridamole. ... -Finanzen.net

Proton-Pump Inhibitors Decrease Risk of NSAID-Induced ...  Jun 30, 2006
There was no difference in use of corticosteroids (13.5% vs 11.3%), selective serotonin re-uptake inhibitors (5.8% vs 3.2%), clopidogrel/dipyridamole (4.8% vs ... -DG News



In Vitro Evaluation of Adenosine 5'-Monophosphate as an Imaging ...  Apr 26, 2006
Selected cells were exposed to caffeine, dipyridamole, adenosine 5'-( ,ß-methylene)diphosphate (APCP), or unlabeled adenosine before exposure to the ... - Journal of Nuclear Medicine





Clopidogrel Treatment Prior to Percutaneous Coronary Intervention  Apr 4, 2006
3. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. ... - Journal of American Medical Association (subscription)

Secondary Stroke Prevention Guidelines Call for Upgrade of TIA ...  Feb 21, 2006
For reduction in risk of recurrent stroke, antiplatelet therapy with aspirin alone, aspirin plus extended release dipyridamole or clopidogrel are all options ... - Medscape (subscription)

CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 ...  Jan 30, 2006
AUSCAN scale. CRx-102 was dosed in this trial using 3mg of prednisolone and two different doses of dipyridamole. Patients received ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional